[go: up one dir, main page]

FR2278335B1 - - Google Patents

Info

Publication number
FR2278335B1
FR2278335B1 FR7520990A FR7520990A FR2278335B1 FR 2278335 B1 FR2278335 B1 FR 2278335B1 FR 7520990 A FR7520990 A FR 7520990A FR 7520990 A FR7520990 A FR 7520990A FR 2278335 B1 FR2278335 B1 FR 2278335B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7520990A
Other languages
French (fr)
Other versions
FR2278335A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP49077091A external-priority patent/JPS51125061A/en
Priority claimed from JP49085526A external-priority patent/JPS51125062A/en
Priority claimed from JP49088452A external-priority patent/JPS51125064A/en
Priority claimed from JP50002650A external-priority patent/JPS5175056A/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of FR2278335A1 publication Critical patent/FR2278335A1/en
Application granted granted Critical
Publication of FR2278335B1 publication Critical patent/FR2278335B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7520990A 1974-07-04 1975-07-03 DERIVATIVES OF AZETIDINONES AND THEIR PREPARATION METHODS Granted FR2278335A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP49077091A JPS51125061A (en) 1974-07-04 1974-07-04 A process for 3-acylaminoazetidinone derivatives
JP49085526A JPS51125062A (en) 1974-07-24 1974-07-24 A process for preparing 3-aminoazetidinone
JP49088452A JPS51125064A (en) 1974-07-31 1974-07-31 A process for preparing 1-substituted-3- acylaminoazetidinone derivati ves
JP50002650A JPS5175056A (en) 1974-12-23 1974-12-23 33 chikanazejinonjudotaino seizoho

Publications (2)

Publication Number Publication Date
FR2278335A1 FR2278335A1 (en) 1976-02-13
FR2278335B1 true FR2278335B1 (en) 1982-12-17

Family

ID=27453685

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7520990A Granted FR2278335A1 (en) 1974-07-04 1975-07-03 DERIVATIVES OF AZETIDINONES AND THEIR PREPARATION METHODS

Country Status (4)

Country Link
DE (1) DE2529941A1 (en)
FR (1) FR2278335A1 (en)
GB (1) GB1519495A (en)
NZ (1) NZ178019A (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207234A (en) * 1975-07-07 1980-06-10 Fujisawa Pharmaceutical Co., Ltd. 4-Unsubstituted azetidinone derivatives and process for preparation thereof
JPS5261291A (en) * 1975-11-14 1977-05-20 Fujisawa Pharmaceut Co Ltd Preparation of fr-29611 substance and/or fr-29612 substance
NL7806860A (en) 1977-07-05 1979-01-09 Farmaceutici Italia PROCESS FOR PREPARING NOCARDICIN-RELATED AZETIDINONES.
US4195021A (en) * 1977-10-26 1980-03-25 Eli Lilly And Company 1,3-Disubstituted 2-azetidinone antibitotics
EP0005507A1 (en) * 1978-05-18 1979-11-28 Ciba-Geigy Ag Process for the fragmentation of 3-(2-hydroxyimino-acetylamino)-2-oxo azetidin compounds and compounds obtained thereby
DE3069587D1 (en) * 1979-06-08 1984-12-13 Takeda Chemical Industries Ltd 1-sulpho-2-oxoazetidine derivatives, their production and pharmaceutical compositions thereof
CA1242188A (en) * 1979-06-08 1988-09-20 Takeda Pharmaceutical Company Limited 3-methoxy-2-oxoazetidine derivatives and their production
US4337197A (en) 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
GR77929B (en) * 1981-01-29 1984-09-25 Fujisawa Pharmaceutical Co
EP0201999A1 (en) * 1985-04-16 1986-11-20 Imperial Chemical Industries Plc Substituted 2-cyano-2-oximino-acetamides, processes for their production and their use as fungicides
US6635632B1 (en) 1996-12-23 2003-10-21 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
HRP970705A2 (en) * 1996-12-23 1998-10-31 Warren J. Porter CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING "beta" -AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
US6683075B1 (en) 1996-12-23 2004-01-27 Athena Neurosciences, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use
US6528505B1 (en) 1998-06-22 2003-03-04 Elan Pharmaceuticals, Inc. Cyclic amino acid compounds pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6774125B2 (en) 1998-06-22 2004-08-10 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6509331B1 (en) 1998-06-22 2003-01-21 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6569851B1 (en) 1998-06-22 2003-05-27 Elan Pharmaceutials, Inc. Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6552013B1 (en) 1998-06-22 2003-04-22 Elan Pharmaceuticals, Inc. Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
US6958330B1 (en) 1998-06-22 2005-10-25 Elan Pharmaceuticals, Inc. Polycyclic α-amino-ε-caprolactams and related compounds
JPWO2007013694A1 (en) * 2005-07-29 2009-02-12 武田薬品工業株式会社 Phenoxyalkanoic acid compound
DK2484680T3 (en) * 2005-12-07 2013-09-08 Basilea Pharmaceutica Ag Useful combinations of monolactam antibiotics with beta-lactamase inhibitors
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US7601856B2 (en) 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
US7662831B2 (en) 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
CN115925585B (en) * 2022-04-22 2023-11-03 广州医科大学 Chlorphenol derivatives, antibacterial drugs, preparation methods and applications

Also Published As

Publication number Publication date
DE2529941A1 (en) 1976-04-08
GB1519495A (en) 1978-07-26
FR2278335A1 (en) 1976-02-13
NZ178019A (en) 1978-04-28

Similar Documents

Publication Publication Date Title
FR2256499A1 (en)
FR2257500A1 (en)
AU7475874A (en)
DK158075A (en)
AU7462274A (en)
AU495028B2 (en)
AU495844B2 (en)
DK532074A (en)
AU6599774A (en)
AU7474774A (en)
CS175769B1 (en)
CS167442B1 (en)
CS166393B1 (en)
CH598177A5 (en)
BG19725A1 (en)
DD115545A1 (en)
DD113229A1 (en)
DD119709A5 (en)
DD120442A5 (en)
DD112219A1 (en)
CH605882A5 (en)
CH604184A5 (en)
CH603159A5 (en)
CH599392B5 (en)
AU480922A (en)

Legal Events

Date Code Title Description
ST Notification of lapse